IDiyas

For the Inventor, By the Inventor

Vancouver, Canada

Jeffery R Raymond

USPTO Granted Patents = 14 

 

Average Co-Inventor Count = 5.1

ph-index = 6

Forward Citations = 63(Granted Patents)


Company Filing History:

goldMedal8 out of 9 
 
Aquinox Pharmaceuticals (canada) Inc.
 patents
silverMedal4 out of 5 
 
Aquinox Pharmaceuticals Inc.
 patents
bronzeMedal2 out of 11 
 
Inflazyme Pharmaceuticals Ltd.
 patents

Years Active: 2003-2019

Loading Chart...
Loading Chart...
14 patents (USPTO):Explore Patents
1. 10272081 - SHIP1 modulators and methods related thereto (2019-04-30),
2. 10174046 - SHIP1 modulators and methods related thereto (2019-01-08),
3. 10100056 - SHIP1 modulators and methods related thereto (2018-10-16),
4. 10065920 - Crystalline solid forms of the acetate salt of (1S,3S,4R)-4-((3AS,4R,5S,7AS)-4-(aminomethyl)-7A-methyl-1-methyleneoctahydro-1H-inden-5-YL)-3- (hydroxymethyl)-4-methylcyclohexanol (2018-09-04),
5. 9944590 - Crystalline solid forms of the acetate salt of (1S,3S,4R)-4-((3aS,4R,5S,7aS)-4-(aminomethyl)-7a-methyl-1-methyleneoctahydro-1H-inden-5-yl)-3-(hydroxymethyl)-4-methylcyclohexanol (2018-04-17),
6. 9937167 - SHIP1 modulators and methods related thereto (2018-04-10),
7. 9765085 - SHIP1 modulators and methods related thereto (2017-09-19),
8. 9540353 - SHIP1 modulators and methods related thereto (2017-01-10),
9. 8673975 - Indene derivatives as pharmaceutical agents (2014-03-18),
10. 8084503 - Indene derivatives as pharmaceutical agents (2011-12-27),
11. 7999010 - Indene derivatives as pharmaceutical agents (2011-08-16),
12. 7601874 - Indene derivatives as pharmaceutical agents (2009-10-13),
13. 7112580 - 3-nitrogen-6, 7-dioxygen steroids and uses related thereto (2006-09-26),
14. 6635629 - 3-nitrogen-6,7-dioxygen steroids and uses related thereto (2003-10-21),

Title: Jeffery R Raymond: Innovator in SHIP1 Modulation

Introduction

Jeffery R Raymond is a prominent inventor based in Vancouver, Canada. He has made significant contributions to the field of pharmaceuticals, particularly in the development of SHIP1 modulators. With a total of 14 patents to his name, Raymond's work has the potential to impact the treatment of various diseases and disorders.

Latest Patents

Raymond's latest patents include innovative compounds that act as SHIP1 modulators. One of his notable patents describes compounds of formula (I), which are designed to treat a variety of diseases, disorders, or conditions that would benefit from SHIP1 modulation. These compounds can be used in combination with pharmaceutically acceptable carriers or diluents. Another patent focuses on compounds of formula (II), which also exhibit activity as SHIP1 modulators. These compounds may be useful in treating similar conditions and include various stereoisomers, enantiomers, or tautomers.

Career Highlights

Throughout his career, Jeffery R Raymond has worked with Aquinox Pharmaceuticals Inc. and Aquinox Pharmaceuticals (Canada) Inc. His experience in these companies has allowed him to develop and refine his innovative ideas in the pharmaceutical industry.

Collaborations

Raymond has collaborated with notable colleagues, including Lloyd F Mackenzie and Curtis Harwig. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Jeffery R Raymond is a distinguished inventor whose work in SHIP1 modulation holds promise for the treatment of various medical conditions. His contributions to the field are marked by a strong portfolio of patents and collaborations with esteemed colleagues.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…